Related Experiment Videos
DNA quantification in colorectal carcinoma using flow and image analysis cytometry.
R E Fausel1, W Burleigh, D B Kaminsky
1Department of Pathology, Los Angeles County Harbor-University of California, Torrance.
Analytical and Quantitative Cytology and Histology
|February 1, 1990
Summary
DNA quantification in colorectal carcinoma is a significant prognostic indicator. Image cytometry (ICM) offers comparable, potentially more sensitive, DNA analysis than flow cytometry (FCM), aiding in patient survival prediction.
Area of Science:
- Oncology
- Pathology
- Biotechnology
Background:
- Flow cytometry (FCM) has established DNA quantification and ploidy classification as prognostic indicators in colorectal carcinoma.
- Recent advancements in image analysis cytometry (image cytometry, ICM) present a novel alternative for DNA quantification.
Purpose of the Study:
- To determine if diploid DNA patterns in colorectal carcinomas correlate with improved five-year survival compared to non-diploid patterns.
- To assess the comparability and sensitivity of ICM for DNA quantification against FCM.
Main Methods:
- DNA quantification and ploidy classification were performed on 27 archival paraffin-embedded colorectal carcinoma tissues.
- Both flow cytometry (FCM) and image cytometry (ICM) techniques were utilized for comparative analysis.
Main Results:
- A significant proportion of tumors were classified as non-diploid by both ICM (70%) and FCM (56%).
- Diploid tumors were predominantly associated with Dukes' stage A, while non-diploid tumors correlated with Dukes' stage D.
- Five-year survival rates were higher for patients with diploid tumors (75% ICM, 67% FCM) compared to non-diploid tumors (53%).
Conclusions:
- DNA quantification remains a crucial prognostic factor for colorectal carcinoma patients.
- Image cytometry (ICM) provides comparable quantitative data to FCM and demonstrates potential for increased sensitivity in DNA analysis.